Dr. Gaudencio Olgin, MD

Dr. Olgin practices at DHR Health in Edinburg, Texas, part of DHR Health.

Dr. Olgin's NPI, 1790049732, was assigned on June 25, 2012. Dr. Olgin graduated from University of Texas Southwestern Medical School in 2006. Dr. Olgin holds Texas license P9675.

Dr. Olgin's primary practice is DHR Health, at 5501 South McColl, Edinburg, TX 78539 in Hidalgo County. The practice phone is (956) 362-8677.

Dr. Olgin's primary practice is DHR Health in Edinburg, Texas, part of DHR Health. The medical group on file is Renaissance Surgery Group. Dmand AI also links Dr. Olgin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olgin practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Olgin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Olgin is board certified in urology by the American Board of Urology. Dmand AI has Dr. Olgin's licenses on file in 2 states: Texas and California.

Dmand AI lists enlarged prostate, kidney cysts, kidney removal surgery, kidney stone disease, prostate cancer, prostate surgery, transurethral procedures and urinary endoscopy among the conditions Dr. Olgin treats.

CMS data shows 257 Medicare services from Dr. Olgin across 7 procedure codes in 2024, for 173 Medicare patients. Medicare paid $15,118 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Olgin in 2024. The largest group is 65 to 74, with 80 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Olgin's median patient age at 66, with 42% women.

In 2024, Dr. Olgin wrote 627 Medicare Part D claims for 246 patients. 96% of them were for generic drugs. CMS names the drug for 540 of them, across 6 drugs with 11 or more claims each, at $26,558 in total drug cost. In 2023, CMS named 802 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Olgin for performance year 2024, reported as part of a group. Dr. Olgin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Olgin, published from 2013 to 2017. 2014 was the busiest year, with 4. The most frequent topics are Disease Models, Animal, Kidney Calculi and Nephrostomy, Percutaneous. Dr. Olgin has published most often in J Endourol. Dr. Olgin's most frequent co-authors are Muhannad Mahmoud Alsyouf, MD, Roger Li, MD and Dalton Duane Baldwin, MD.

CMS Open Payments shows 72 general payments to Dr. Olgin from 25 drug and device companies from 2016 to 2025. Education make up the largest share, 66% of the total. Intuitive Surgical, Inc. paid the most, $10,127.

Dr. Olgin graduated from University of Texas Southwestern Medical School in 2006.

Dr. Olgin is in network with 23 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.